Pivotal Response Training for Autism
(PRT-C Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to test the effectiveness of Pivotal Response Treatment (PRT-C) in improving social communication skills in young children with autism. Children will either receive intensive therapy sessions in a center-based setting or continue with their usual treatment, with the option to try PRT-C later. Suitable participants have a confirmed autism diagnosis, are between 2 and 3 years and 11 months old, and have a parent available for training sessions. As an unphased trial, this study provides families with a unique opportunity to explore innovative treatment options for their children.
Will I have to stop taking my current medications?
The trial requires that participants have stable treatment, including medications, for at least 1 month before starting and no changes are expected during the study. So, you should not stop taking your current medications.
What prior data suggests that Pivotal Response Treatment (PRT-C) is safe for children with autism spectrum disorder?
Research has shown that Pivotal Response Treatment (PRT) is an effective therapy for children with autism spectrum disorder (ASD). This treatment, based on applied behavior analysis (ABA), uses rewards to encourage positive behavior.
For many years, PRT has helped children with ASD enhance their social and communication skills. The therapy targets key areas affected by autism, such as social interaction and communication. Studies have found that children generally respond well to PRT.
Negative effects are rare because PRT is a play-based therapy led by the child. The child selects the activities, making sessions more enjoyable and engaging.
Overall, PRT is considered safe for children with autism and has a strong history of improving communication and social skills.12345Why are researchers excited about this trial?
Researchers are excited about Pivotal Response Treatment for Autism because it offers an intensive, structured approach that actively involves both the child and their parents. Unlike traditional autism therapies, which might focus solely on the child or use less frequent sessions, this treatment combines 12 weekly hours of center-based therapy for the child with a weekly parent training session. This dual approach not only aims to improve the child's communication and social skills but also empowers parents with strategies to support their child's development, potentially leading to more consistent and lasting improvements.
What evidence suggests that Pivotal Response Treatment might be an effective treatment for autism?
Research has shown that Pivotal Response Treatment (PRT) can improve social communication skills in children with autism. PRT is a therapy that uses everyday situations to teach new skills, and studies indicate it can enhance social and emotional behaviors. The goal is to increase children's motivation and help them apply what they learn in therapy to their daily lives. In this trial, participants will join either the Intensive Center-Based Pivotal Response Treatment (PRT-C) group or the Delayed Treatment Group (DTG). However, some reviews found that PRT did not clearly improve communication or language skills. Overall, PRT is considered a promising method for helping children with autism improve certain behaviors.12367
Who Is on the Research Team?
Antonio Hardan, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for preschoolers aged 2 to almost 4 years with Autism Spectrum Disorder (ASD), who have a developmental delay and are English-speaking. They should be on stable treatment without changes expected during the study, and must not have had an adequate trial of Pivotal Response Treatment before.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Intensive Center-Based Pivotal Response Treatment (PRT-C) consisting of one weekly 60-minute individual parent training session and 12 weekly hours with the child in a center-based therapy environment
Delayed Treatment Group (DTG)
Participants receive treatment as usual, with the option to receive PRT-C in a preschool setting after the controlled phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Pivotal Response Treatment (PRT-C)
Pivotal Response Treatment (PRT-C) is already approved in United States, European Union, Canada for the following indications:
- Autism Spectrum Disorder (ASD)
- Autism Spectrum Disorder (ASD)
- Autism Spectrum Disorder (ASD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
John & Marcia Goldman Foundation
Collaborator